Trupanion (NASDAQ:TRUP) Announces Earnings Results, Beats Expectations By $0.05 EPS

Trupanion (NASDAQ:TRUP) posted its earnings results on Wednesday. The financial services provider reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05, FiscalAI reports. The company had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. Trupanion had a net margin of 1.74% and a return on equity of 6.87%.

Here are the key takeaways from Trupanion’s conference call:

• Subscription performance strengthened: Subscription adjusted operating income rose 24% year over year to $41.4 million, with a 15% margin, while subscription pets increased 5% to 1.125 million and retention improved to 98.37%.
• Improved acquisition economics helped drive a 9% increase in gross pet adds and 39% growth in net subscription pet additions. Management said enrolled-pet lifetime value increased 25%, supporting continued investment in customer acquisition.
• Trupanion authorized a $100 million share repurchase program after securing approval to transfer $44 million from an insurance subsidiary, adding buybacks to its capital-allocation options alongside growth investments and debt repayment.
• Management narrowed full-year 2026 guidance to $1.584 billion-$1.601 billion in revenue and $176 million-$184 million in adjusted operating income, implying approximately 19% adjusted operating income growth at the midpoint.
• Veterinary inflation remains at double-digit levels, while industry reports indicate fewer new veterinary visits; management also disclosed that its relationship with Pets Best will end after the third quarter of 2028.

Trupanion Stock Performance

Shares of NASDAQ TRUP traded down $0.26 during midday trading on Wednesday, reaching $24.39. The company had a trading volume of 376,966 shares, compared to its average volume of 415,357. Trupanion has a 1 year low of $21.16 and a 1 year high of $57.00. The business’s 50-day simple moving average is $24.44 and its 200 day simple moving average is $26.26. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The stock has a market cap of $1.06 billion, a P/E ratio of 41.34 and a beta of 1.39.

Insider Activity

In related news, COO John R. Gallagher sold 3,603 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the transaction, the chief operating officer directly owned 33,065 shares of the company’s stock, valued at $717,179.85. This represents a 9.83% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Steve Weinrauch sold 6,674 shares of the company’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the completion of the transaction, the executive vice president directly owned 78,062 shares in the company, valued at approximately $1,717,364. The trade was a 7.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 17,807 shares of company stock valued at $394,452 over the last ninety days. 5.58% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Kemnay Advisory Services Inc. purchased a new stake in Trupanion in the fourth quarter valued at approximately $64,000. Kelleher Financial Advisors purchased a new position in Trupanion during the 3rd quarter worth approximately $74,000. Advisory Services Network LLC acquired a new stake in Trupanion during the 3rd quarter valued at approximately $160,000. Tidal Investments LLC acquired a new stake in Trupanion during the 2nd quarter valued at approximately $212,000. Finally, Renaissance Technologies LLC purchased a new stake in shares of Trupanion in the 4th quarter valued at $224,000.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on TRUP shares. Cantor Fitzgerald reduced their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Atlantic Securities set a $42.00 target price on Trupanion in a research note on Wednesday, July 15th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Finally, Bank of America lowered their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Trupanion currently has a consensus rating of “Moderate Buy” and an average price target of $41.60.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.